Plasmid DNA size does affect nonviral gene delivery efficiency in stem cells

Cellular Reprogramming

Volumn 14, Issue 2, 2012, Pages 130-137

  Ribeiro, Sofia ^a   Mairhofer, Juergen ^b   Madeira, Catarina ^a   Diogo, Maria Margarida ^a   Lobato Da Silva, Cláudia ^a   Monteiro, Gabriel ^a   Grabherr, Reingard ^b   Cabral, Joaquim M ^a  

^a INSTITUTO SUPERIOR TÉCNICO   (Portugal)

^b UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; MESSENGER RNA; PLASMID DNA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE DOSAGE; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MOUSE; NEURAL STEM CELL; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PLASMID; PRIORITY JOURNAL; R FACTOR; STEM CELL EXPANSION;

ANIMALS; BASE SEQUENCE; CELLS, CULTURED; DNA; EFFICIENCY; ELECTROPORATION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; MICE; PLASMIDS; STEM CELLS; TRANSFECTION; TRANSGENES;

EID: 84859514561     PISSN: 21524971     EISSN: 21524998     Source Type: Journal    
DOI: 10.1089/cell.2011.0093     Document Type: Article

References (43)

1. Akita, H., Ito, R., Kamiya, H., et al. (2007). Cell cycle dependent transcription, a determinant factor of heterogeneity in cationic lipid-mediated transgene expression. J. Gene Med. 9, 197-207. (Pubitemid 46523537)
2. Argyros, O., Wong, S.P., Fedonidis, C., et al. (2011). Development of S/MAR minicircles for enhanced and persistent transgene expression in the mouse liver. J. Mol. Med. (Berl.) 89, 515-529.
3. Azzoni, A., Ribeiro, S., Monteiro, G., et al. (2007). The impact of polyadenylation signals on plasmid nuclease-resistance and transgene expression. J. Gene Med. 9, 392-402. (Pubitemid 46796585)
4. Bigger, B.W., Tolmachov, O., Collombet, J.M., et al. (2001). An araC-controlled bacterial cre expression system to produce DNA minicircle vectors for nuclear and mitochondrial gene therapy. J. Biol. Chem. 276, 23018-23027.
5. Brown, A.B., Yang, W., Schmidt, N.O., et al. (2003). Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin. Hum. Gene Ther. 14, 1777-1785. (Pubitemid 38010667)
6. Chen, Z., He, C., Ehrhardt, A., et al. (2003). Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo. Mol. Ther. 8, 495-500. (Pubitemid 37161471)
7. Chen, Z., He, C., Meuse, L., et al. (2004). Silencing of episomal transgene expression by plasmid bacterial DNA elements in vivo. Gene Ther. 11, 856-864. (Pubitemid 38714589)
8. Chen, Z.-Y., Riu, E., He, C.-Y., et al. (2008). Silencing of episomal transgene expression in liver by plasmid bacterial backbone DNA is independent of CpG methylation. Mol. Ther. 16, 548-556. (Pubitemid 351314995)
9. Clements, B.A., Incani, V., Kucharski, C., et al. (2007). A comparative evaluation of poly-L-lysine-palmitic acid and Lipofectamine (TM) 2000 for plasmid delivery to bone marrow stromal cells. Biomaterials 28, 4693-4704. (Pubitemid 47259175)
10. Cohen, R.N., van der Aa, M., Macaraeg, N., et al. (2009). Quantification of plasmid DNA copies in the nucleus after lipoplex and polyplex transfection. J. Control Release 135, 166-174.
11. Dos Santos, F., Andrade, P.Z., Boura, J.S., et al. (2010). Ex vivo expansion of human mesenchymal stem cells: a more effective cell proliferation kinetics and metabolism under hypoxia. J. Cell Physiol. 223, 27-35.
12. Falk, A., Holmström, N., Carlén, M., et al. (2002). Gene delivery to adult neural stem cells. Exp. Cell Res. 279, 34-39.
13. Fujiwara, Y., Tanaka, N., Ishida, O., et al. (2004). Intravenously injected neural progenitor cells of transgenic rats can migrate to the injured spinal cord and differentiate into neurons, astrocytes and oligodendrocytes. Neurosci. Lett. 366, 287-291. (Pubitemid 39024283)
14. Gheisari, Y., Soleimani, M., Azadmanesh, K., et al. (2008). Multipotent mesenchymal stromal cells: optimization and comparison of five cationic polymer-based gene delivery methods. Cytotherapy 10, 815-823.
15. Hodges, B.L., Taylor, K.M., Joseph, M.F., et al. (2004). Long-term transgene expression from plasmid DNA gene therapy vectors is negatively affected by CpG dinucleotides. Mol. Ther. 10, 269-278. (Pubitemid 39117873)
16. Hsu, C.Y., and Uludag, H. (2008). Effects of size and topology of DNA molecules on intracellular delivery with non-viral gene carriers. BMC Biotechnol. 8, 23. (Pubitemid 351448058)
17. Hyde, S.C., Pringle, I.A., Abdullah, S., et al. (2008). CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression. Nat. Biotechnol. 26, 549-551. (Pubitemid 351668040)
18. Jia, F., Wilson, K., Sun, N., et al. (2010). A nonviral minicircle vector for deriving human iPS cells. Nat. Methods 7, 197-199.
19. Jo, J., and Tabata, Y. (2008). Non-viral gene transfection technologies for genetic engineering of stem cells. Eur. J. Pharm. Biopharm. 68, 90-104. (Pubitemid 350181423)
20. Kern, S., Eichler, H., Stoeve, J., et al. (2006). Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24, 1294-1301. (Pubitemid 44464698)
21. Kreiss, P., Cameron, B., Rangara, R., et al. (1999). Plasmid DNA size does not affect the physicochemical properties of lipoplexes but modulates gene transfer efficiency. Nucleic Acids Res. 27, 3792-3798. (Pubitemid 29454426)
22. Lim, J.Y., Park, S.H., Jeong, C.H., et al. (2010). Microporation is a valuable transfection method for efficient gene delivery into human umbilical cord blood-derived mesenchymal stem cells. BMC Biotechnol. 10, 38.
23. Lukacs, G., Haggie, P., Seksek, O., et al. (2000). Size-dependent DNA mobility in cytoplasm and nucleus. J. Biol. Chem. 275, 1625-1629. (Pubitemid 30060778)
24. Luo, D., and Saltzman, W. (2000). Synthetic DNA delivery systems. Nat. Biotechnol. 18, 33-37. (Pubitemid 30041168)
25. Madeira, C., Mendes, R.D., Ribeiro, S.C., et al. (2010). Nonviral gene delivery to mesenchymal stem cells using cationic liposomes for gene and cell therapy. J. Biomed. Biotechnol. 2010, 735349.
26. Madeira, C., Ribeiro, S.C., Pinheiro, I.S., et al. (2011). Gene delivery to human bone marrow mesenchymal stem cells by microporation. J. Biotechnol. 151, 130-136.
27. Mairhofer, J., and Grabherr, R. (2008). Rational vector design for efficient non-viral gene delivery: challenges facing the use of plasmid DNA. Mol. Biotechnol. 39, 97-104.
28. Mairhofer, J., Pfaffenzeller, I., Merz, D., et al. (2008). A novel antibiotic free plasmid selection system: advances in safe and efficient DNA therapy. Biotechnol. J. 3, 83-89. (Pubitemid 351200934)
29. Mairhofer, J., Cserjan-Puschmann, M., Striedner, G., et al. (2010). Marker-free plasmids for gene therapeutic applications-lack of antibiotic resistance gene substantially improves the manufacturing process. J. Biotechnol. 146, 130-137.
30. Maucksch, C., Bohla, A., Hoffmann, F., et al. (2009). Transgene expression of transfected supercoiled plasmid DNA concatemers in mammalian cells. J. Gene Med. 11, 444-453.
31. McLenachan, S., Sarsero, J.P., and Ioannou, P.A. (2007). Flowcytometric analysis of mouse embryonic stem cell lipofection using small and large DNA constructs. Genomics 89, 708-720. (Pubitemid 46719795)
32. McMahon, J., Wells, K., Bamfo, J., et al. (1998). Inflammatory responses following direct injection of plasmid DNA into skeletal muscle. Gene Ther. 5, 1283-1290. (Pubitemid 28448438)
33. Moriguchi, R., Kogure, K., and Harashima, H. (2008). Non-linear pharmacodynamics in the transfection efficiency of a non-viral gene delivery system. Int. J. Pharm. 363, 192-198.
34. Müller, F., Snyder, E., and Loring, J. (2006). Gene therapy: can neural stem cells deliver? Nat. Rev. Neurosci. 7, 75-84. (Pubitemid 41828933)
35. Ribeiro, S.C., Monteiro, G.A., and Prazeres, D.M.F. (2004). The role of polyadenytation signal secondary structures on the resistance of plasmid vectors to nucleases. J. Gene Med. 6, 565-573. (Pubitemid 40228072)
36. Ribeiro, S.C., Mendes, R., Madeira, C., et al. (2010). A quantitative method to evaluate mesenchymal stem cell lipofection using real-time PCR. Biotechnol. Prog. 26, 1501-1504.
37. Tachibana, R., Harashima, H., Ide, N., et al. (2002). Quantitative analysis of correlation between number of nuclear plasmids and gene expression activity after transfection with cationic liposomes. Pharm. Res. 19, 377-381. (Pubitemid 34408932)
38. Tomanin, R., and Scarpa, M. (2004). Why do we need new gene therapy viral vectors? Characteristics, limitations and future perspectives of viral vector transduction. Curr. Gene Ther. 4, 357-372. (Pubitemid 39534752)
39. Vaughan, E.E., and Dean, D.A. (2006). Intracellular trafficking of plasmids during transfection is mediated by microtubules. Mol. Ther. 13, 422-428. (Pubitemid 43056908)
40. Vaysse, L., Gregory, L.G., Harbottle, R.P., et al. (2006). Nucleartargeted minicircle to enhance gene transfer with non-viral vectors in vitro and in vivo. J. Gene Med. 8, 754-763.
41. Yew, N., Wang, K., Przybylska, M., et al. (1999). Contribution of plasmid DNA to inflammation in the lung after administration of cationic lipid:pDNA complexes. Hum. Gene Ther. 10, 223-234. (Pubitemid 29070636)
42. Yew, N., Zhao, H., Wu, I., et al. (2000). Reduced inflammatory response to plasmid DNA vectors by elimination and inhibition of immunostimulatory CpG motifs. Mol. Ther. 1, 255-262.
43. Yew, N., Zhao, H., Przybylska, M., et al. (2002). CpG-depleted plasmid DNA vectors with enhanced safety and long-term gene expression in vivo. Mol. Ther. 5, 731-738. (Pubitemid 34619066).